✦ LIBER ✦

TCT-302 Evaluation of the Novel DESolve Myolimus-Eluting Bioresorbable Coronary Scaffold System for Treatment of De Novo Coronary Arteries: Six-Month Optical Coherence Tomography Results from the DESolve FIM Trial

✍ Scribed by Daniel Chamie; Jose Costa Jr; Alexandre Abizaid; Mark Webster; James Stewart; Ricardo Costa; John Yan; vinayak bhat; lynn morrison; Sara Toyloy; John Ormiston; Stefan Verheye

Book ID: 119272378
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 58 KB
Volume: 60
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2012.08.326

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-600 Six-Month Results of the DESolve

TCT-600 Six-Month Results of the DESolve Novolimus-Eluting Bioresorbable Scaffold for the Treatment of Single, De Novo, Coronary Artery Lesions: Serial OCT Analysis from the Pivotal, Prospective Multicenter DESolve NX

✍ Chamie, Daniel; Verheye, Stefan; Schofer, Joachim; Costa, Jose D.; Costa, Ricard 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB

TCT-39 6-Month Angiographic Follow-up of

TCT-39 6-Month Angiographic Follow-up of the Novel DESolveTM Myolimus-Eluting Bioresorbable Coronary Scaffold for the Treatment of Non-Complex Coronary Lesions – Results from the DESolve I First-In-Man Trial

✍ Ricardo Costa; Alexandre Abizaid; Mark Webster; James Stewart; Jose Costa Jr; ly 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

TCT-431 Angiographic Results of a novel

TCT-431 Angiographic Results of a novel Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) for the treatment of single de-novo coronary artery lesions: 6 month Serial QCA analysis results from the pivotal, prospective, multicentre, DESolve NX Trial

✍ Costa, Ricardo A.; Verheye, Stefan; Schofer, Joachim; Costa, Jose d; Chamié, Dan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 72 KB

TCT-596 Early Vascular Restoration follo

TCT-596 Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights from the Serial IVUS analysis of the pivotal, prospective, multicentre, DESolve NX Trial

✍ Costa, Jose D.; Schofer, Joachim; Verheye, Stefan; Toyloy, Sara; Chamié, Daniel; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 71 KB

TCT-37: ABSORB Cohort B Trial: 9 Months

TCT-37: ABSORB Cohort B Trial: 9 Months Clinical Results of the Evaluation of the Bioresorbable Everolimus-Eluting Vascular Scaffold (BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 146 KB